When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - Gilead an acquisition target? Deep pockets required
Bristol-Myers Squibb Company
Jefferies' Michael Yee says investors believe that Gilead Sciences (GILD+0.6%) is an acquisition target considering its near-term share performance (at the same level as three years ago with some volatility thrown in) and tepid growth prospects (little or no topline increase expected this year).
More news on: Gilead Sciences, Inc., Allergan plc, AbbVie Inc., Healthcare stocks news, Merger & acquisition news,